127 related articles for article (PubMed ID: 10522698)
1. Synthesis and pharmacological profile of 1-aryl-3-substituted pyrrolo[3,2-c]quinolines.
Yum EK; Kang SK; Kim SS; Choi JK; Cheon HG
Bioorg Med Chem Lett; 1999 Oct; 9(19):2819-22. PubMed ID: 10522698
[TBL] [Abstract][Full Text] [Related]
2. Synthesis of 4-(phenylamino)quinoline-3-carboxamides as a novel class of gastric H+/K+-ATPase inhibitors.
Uchida M; Otsubo K; Matsubara J; Ohtani T; Morita S; Yamasaki K
Chem Pharm Bull (Tokyo); 1995 Apr; 43(4):693-8. PubMed ID: 7600619
[TBL] [Abstract][Full Text] [Related]
3. Biochemical and pharmacological characteristics of 3-butyryl-8-methoxy-4-[(2-thiophenyl)amino]quinoline, a new proton-pump inhibitor, in rabbit gastric microsomes and in rats.
Kim KB; Chang MS; Chung YK; Sohn SK; Kim SG; Choi WS
J Pharm Pharmacol; 1998 May; 50(5):521-9. PubMed ID: 9643446
[TBL] [Abstract][Full Text] [Related]
4. Pharmacological properties of a newly synthesized H(+)/K(+) ATPase inhibitor, 1-(2-methyl-4-methoxyphenyl)-4-.
Cheon HG; Lee SS; Lim H; Lee DH
Eur J Pharmacol; 2001 Jan; 411(1-2):187-192. PubMed ID: 11137875
[TBL] [Abstract][Full Text] [Related]
5. Anti-ulcer activity of newly synthesized acylquinoline derivatives.
Cheon HG; Kim HJ; Mo HK; Shin E; Lee Y
Arch Pharm Res; 1999 Apr; 22(2):137-42. PubMed ID: 10230503
[TBL] [Abstract][Full Text] [Related]
6. Pharmacological studies on the new quinoline derivative 1-(2-methylphenyl)-4-[(3-hydroxypropyl) amino]-6-trifluoromethoxy-2,3-dihydropyrrolo[3,2-c] quinoline with potent anti-ulcer effect.
Cheon HG; Kim HJ; Kim SS; Choi JK; Kong JY
Arzneimittelforschung; 1998 Dec; 48(12):1168-71. PubMed ID: 9893932
[TBL] [Abstract][Full Text] [Related]
7. Biochemical and pharmacological properties of a newly synthesized proton pump (H+/K(+)-ATPase) inhibitor, TY-11345 in experimental animals.
Yamaguchi T; Aihara K; Yamada S; Narita S; Kogi K
Jpn J Pharmacol; 1993 Aug; 62(4):363-71. PubMed ID: 8230863
[TBL] [Abstract][Full Text] [Related]
8. A novel class of antiulcer agents. 4-Phenyl-2-(1-piperazinyl)quinolines.
Hino K; Kawashima K; Oka M; Nagai Y; Uno H; Matsumoto J
Chem Pharm Bull (Tokyo); 1989 Jan; 37(1):110-5. PubMed ID: 2720842
[TBL] [Abstract][Full Text] [Related]
9. Synthesis and antiulcer activity of 4-substituted 8-[(2-benzimidazolyl)sulfinylmethyl]-1,2,3,4-tetrahydroquinoli nes and related compounds.
Uchida M; Chihiro M; Morita S; Yamashita H; Yamasaki K; Kanbe T; Yabuuchi Y; Nakagawa K
Chem Pharm Bull (Tokyo); 1990 Jun; 38(6):1575-86. PubMed ID: 2170036
[TBL] [Abstract][Full Text] [Related]
10. Studies on proton pump inhibitors. II. Synthesis and antiulcer activity of 8-[(2-benzimidazolyl)sulfinylmethyl]-1,2,3,4-tetrahydroquinolines and related compounds.
Uchida M; Chihiro M; Morita S; Kanbe T; Yamashita H; Yamasaki K; Yabuuchi Y; Nakagawa K
Chem Pharm Bull (Tokyo); 1989 Aug; 37(8):2109-16. PubMed ID: 2557164
[TBL] [Abstract][Full Text] [Related]
11. Gastroprotective and anti-secretory mechanisms of 2-phenylquinoline, an alkaloid isolated from Galipea longiflora.
Breviglieri E; Mota da Silva L; Boeing T; Somensi LB; Cury BJ; Gimenez A; Cechinel Filho V; de Andrade SF
Phytomedicine; 2017 Feb; 25():61-70. PubMed ID: 28190472
[TBL] [Abstract][Full Text] [Related]
12. 5,6,7,8-Tetrahydroguinolines. 4. Antiulcer and antisecretory activity of 5,6,7,8-tetrahydroquinolinenitriles and -thioamides.
Beattie DE; Crossley R; Curran AC; Dixon GT; Hill DG; Lawrence AE; Shepherd RG
J Med Chem; 1977 May; 20(5):714-8. PubMed ID: 857022
[TBL] [Abstract][Full Text] [Related]
13. Synthesis and drug efficacy validations of racemic-substituted benzimidazoles as antiulcer/antigastric secretion agents.
Radhamanalan R; Alagumuthu M; Nagaraju N
Future Med Chem; 2018 Aug; 10(15):1805-1820. PubMed ID: 30019937
[TBL] [Abstract][Full Text] [Related]
14. Studies on proton pump inhibitors. I. Synthesis of 8-[(2-benzimidazolyl)sulfinyl]-5,6,7,8-tetrahydroquinolines and related compounds.
Uchida M; Morita S; Chihiro M; Kanbe T; Yamasaki K; Yabuuchi Y; Nakagawa K
Chem Pharm Bull (Tokyo); 1989 Jun; 37(6):1517-23. PubMed ID: 2550154
[TBL] [Abstract][Full Text] [Related]
15. The biochemical and pharmacological properties of a newly synthesized H+-K+ ATPase inhibitor, 2-dimethylamino-4,5-dihydrothiazolo[4,5:3,4]pyridol-[1,2-a]benzimidazol e.
Chung YK; Chang MS; Kim KB; Sohn SK; Woo TW; Lee SB; Choi WS
Can J Physiol Pharmacol; 1998 Sep; 76(9):921-9. PubMed ID: 10066143
[TBL] [Abstract][Full Text] [Related]
16. Pharmacological reports about gastroprotective effects of methanolic extract from leaves of Solidago chilensis (Brazilian arnica) and its components quercitrin and afzelin in rodents.
de Barros M; Mota da Silva L; Boeing T; Somensi LB; Cury BJ; de Moura Burci L; Santin JR; de Andrade SF; Monache FD; Cechinel-Filho V
Naunyn Schmiedebergs Arch Pharmacol; 2016 Apr; 389(4):403-17. PubMed ID: 26758066
[TBL] [Abstract][Full Text] [Related]
17. Reversible inhibitors of the gastric (H+/K+)-ATPase. 3. 3-substituted-4-(phenylamino)quinolines.
Ife RJ; Brown TH; Keeling DJ; Leach CA; Meeson ML; Parsons ME; Reavill DR; Theobald CJ; Wiggall KJ
J Med Chem; 1992 Sep; 35(18):3413-22. PubMed ID: 1326634
[TBL] [Abstract][Full Text] [Related]
18. Gastroprotective activity of alkaloid extract and 2-phenylquinoline obtained from the bark of Galipea longiflora Krause (Rutaceae).
Zanatta F; Gandolfi RB; Lemos M; Ticona JC; Gimenez A; Clasen BK; Cechinel Filho V; de Andrade SF
Chem Biol Interact; 2009 Jul; 180(2):312-7. PubMed ID: 19497430
[TBL] [Abstract][Full Text] [Related]
19. Effects of YJA20379-4 on gastric secretion, Helicobacter pylori growth and various gastric and duodenal lesions in rats.
Woo TW; Chang MS; Chung YK; Kim KB; Sohn SK; Kim SG; Choi WS
Biol Pharm Bull; 1998 May; 21(5):449-55. PubMed ID: 9635498
[TBL] [Abstract][Full Text] [Related]
20. 5,6,7,8-Tetrahydroquinolines. 5. Antiulcer and antisecretory activity of 5,6,7,8-tetrahydroquinolinethioureas and related heterocycles.
Beattie DE; Crossley R; Curran AC; Hill DG; Lawrence AE
J Med Chem; 1977 May; 20(5):718-21. PubMed ID: 853507
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
